Find Academic Supervisors

Lisa DuretteView profile

Associate Professor

• Child and Adolescent Psychiatry
• Addiction Medicine
• Child Mental Health Policy and Advocacy
• +4 more

Lisa Durette, MD, serves as Associate Professor and Chair of the Department of Psychiatry and Behavioral Health at the University of Nevada, Las Vegas School of Medicine, while directing the Child and Adolescent Psychiatry Fellowship Program. Board-certified in general psychiatry, child/adolescent psychiatry, and addiction medicine, she holds distinguished fellowships from both the American Academy of Child and Adolescent Psychiatry (AACAP) and American Psychiatric Association (APA). Education: MD: University of South Carolina School of Medicine Psychiatry Residency: Medical University of South Carolina Child/Adolescent Psychiatry Fellowship: Medical University of South Carolina Dr. Durette's research centers on child mental health systems, with emphasis on foster care populations, psychopharmacology disparities, and innovative access models. Her work bridges clinical practice with policy advocacy, particularly through Nevada's child psychiatry access program which connects primary care providers with psychiatric expertise statewide. Analysis of her 2016-2025 publications reveals evolving focus from clinical pharmacology (2016-2020) toward systemic solutions (2022-2025), with consistent attention to foster youth mental health and Nevada-specific service delivery challenges. Key themes include health equity in prescribing practices, child welfare system reform, and sustainable integration of psychiatric services into primary care. Scientific Awards: Distinguished Fellow, American Academy of Child and Adolescent Psychiatry (AACAP) Distinguished Fellow, American Psychiatric Association (APA) As active advocate, Dr. Durette serves on the AACAP Political Action Committee Board, Adoption and Foster Care Committee, and Nevada Governor’s Commission of Mental and Behavioral Health. She co-created Nevada's statewide child psychiatry access program that trains primary care clinicians while addressing workforce shortages. Her leadership extends to AACAP Assembly representation and committee work shaping national child mental health policy. Dr. Durette directs the Child and Adolescent Psychiatry Fellowship while leading departmental operations as Chair. Her team's child psychiatry access program serves as a national model for extending specialty expertise through telehealth consultation and provider education across Nevada's underserved regions.

Wendy J HarrisonView profile

Associate Professor

• Biostatistics
• Causal inference
• Latent variable modelling
• +7 more

Dr Wendy J Harrison is Associate Professor in Biostatistics at the University of Leeds’ School of Medicine, based in the Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) and the Specialist Science Education Department. Since arriving as Lecturer in 2007 she has led quantitative teaching across MBChB and postgraduate programmes, and now directs the Health Informatics with Data Science MSc launched in 2022. Education & Qualifications PhD Latent Variable Modelling for Complex Observational Health Data (part-time, awarded 2017) PGCLTHE – Postgraduate Certificate in Learning and Teaching in Higher Education (2011) MSc Medical Statistics, University of Leicester BSc(Hons) Combined Studies Mathematics / Physics Research Interests Her methodological work focuses on causal inference techniques—especially directed acyclic graphs (DAGs), multilevel and latent-class / latent-variable modelling—for analysing complex observational health data. Applied domains include obesity, cancer epidemiology and paediatric cardiology. She uses insights from this research to embed contemporary quantitative methods into undergraduate and postgraduate medical education. Publications Snapshot Across 15 recent papers (2008-2021) three cross-cutting themes emerge: development and teaching of DAG-based causal inference tools, evaluation of multilevel latent-class methodologies via simulation and real data, and collaborative epidemiological studies in cancer, cardiology and perinatal health. These outputs underline a commitment to both advancing and disseminating robust statistical practice. Professional Memberships Fellow of the Royal Statistical Society (GradStat) Fellow of the Higher Education Academy (FHEA) Leadership & Administration She currently serves as Programme Lead for Postgraduate Programmes in Health Informatics with Data Science, Admissions Lead for all postgraduate programmes in her department, and Chair of the Postgraduate Special Circumstances Committee.

Mimi Stokke OpdalView profile

Associate Professor

• Therapeutic Drug Monitoring
• Clinical Toxicology
• Pharmacokinetics
• +4 more

Mimi Stokke Opdal is an Associate Professor in the Department of Pharmacology at the University of Oslo's Faculty of Medicine. Her research primarily focuses on therapeutic drug monitoring and clinical toxicology, with particular expertise in hypertension treatment adherence, methadone pharmacology, and analytical method development for drug quantification. She maintains an active research profile with publications spanning from the 1990s to the present. Dr. Opdal's research interests center on therapeutic drug monitoring (TDM), clinical toxicology, and pharmacokinetics. Her work has evolved from early studies on cardiac pharmacology and calcium channels to current research on medication adherence in hypertension treatment, methadone pharmacokinetics, and analytical method development for drug quantification. She has made significant contributions to understanding how serum drug concentrations can be used to assess medication adherence and optimize treatment outcomes, particularly in cardiovascular medicine. Analysis of her recent publications (2011-2025) shows a clear focus on therapeutic drug monitoring applications in clinical practice. Her work spans hypertension management, methadone maintenance therapy, antiepileptic drugs, and forensic toxicology. A notable trend is her development and application of advanced analytical techniques (particularly UHPLC-MS/MS) for drug quantification in biological samples, which has enabled more precise therapeutic drug monitoring and improved understanding of medication adherence patterns. Dr. Opdal is actively involved in the Therapeutic Drug Monitoring and Clinical Toxicology research group at the University of Oslo. Her collaborative approach is evident in her numerous multi-author publications involving researchers from various Norwegian hospitals and institutions. While specific grant information isn't provided in the available text, her extensive publication record in high-impact journals suggests successful grant acquisition supporting her research activities. Her laboratory work focuses on analytical method development for drug quantification, particularly using UHPLC-MS/MS techniques. The research group appears to maintain strong clinical connections, conducting studies in emergency departments, hypertension clinics, and with patients in methadone maintenance programs. This translational approach bridges laboratory analytical science with direct clinical applications.

Paul J. LaurientiView profile

Professor

• Magnetic Resonance Imaging
• Aging
• Obesity
• +9 more

Paul J. Laurienti, MD, PhD, is a Professor in the Department of Radiology at Wake Forest University School of Medicine. He directs the Laboratory for Complex Brain Networks (LCBN), a multidisciplinary group focused on understanding complex brain processes like cognition, dementia, and consciousness through network neuroscience approaches. Education: BS (1991), PhD (1995), MD (1999) from University of Texas Research Focus: Aging, Obesity, Pesticide Effects, Alcohol Consumption Techniques: Neural Network Modeling, Functional Connectivity Analysis Funding: NIH grants for mobility declines in aging, weight loss studies, pesticide exposure impacts His work bridges Radiology, Neuroscience, and Public Health through collaborations with centers including the Sticht Center for Healthy Aging and the Center for Addiction Research. Dr. Laurienti employs advanced imaging and computational methods to study brain systems as complex networks.

Isaac S. HarrisView profile

Assistant Professor

• Antioxidant biology
• Cancer metabolism
• Glutathione (GSH) research
• +5 more

Isaac S. Harris is an Assistant Professor at the University of Rochester Medical Center's School of Medicine and Dentistry and Wilmot Cancer Institute, where he leads independent research since September 2019. He received his PhD from the University of Toronto under Dr. Tak Mak and pursued postdoctoral training at Harvard Medical School with Dr. Joan Brugge. Appointments: Department of Biomedical Genetics; Department of Pharmacology and Physiology Research Focus: Antioxidant biology in cancer, particularly glutathione (GSH) and redox regulation Technologies: Developer of Multifunctional Approach to Pharmacologic Screening (MAPS) Research Interests: Dr. Harris investigates how cancer cells exploit antioxidant systems like GSH for tumor initiation and progression. His lab combines in vivo mouse models with high-throughput pharmacologic screening to uncover metabolic vulnerabilities in cancer cells. Key projects explore: GSH's role in cancer initiation and protein homeostasis Redox signaling in tumor microenvironment Metabolic compensation pathways in antioxidant-deprived cancers Development of novel screening technologies (MAPS) Interactions between antioxidant pathways and cell death mechanisms Cross-talk between redox regulation and kinase signaling Publications & Technology: The Harris Lab has published extensively on GSH metabolism in cancer, including breakthrough studies on: Deubiquitinase inhibition as a therapeutic strategy Redox regulation of Th17 and regulatory T cells Cancer cell adaptation to antioxidant depletion Development of physiologic medium screening platforms Lab Members: Current researchers include graduate students Fatemeh Alimohammadi, Gloria Asantewaa, Marco Zocchi, and TashJaé Scales. Alumni include Hayley Chang (MD/PhD student) and technician Leo Schiller.

• Psychosis
• Schizophrenia
• Cannabis Use and Mental Health
• +4 more

Giada Tripoli is a Contract Teacher in the Department of Biomedicine, Neuroscience and Advanced Diagnostics at the University of Palermo's School of Medicine and Surgery. Her research focuses on the complex interplay between environmental factors, substance use, and psychosis development. Her primary research interests center on psychosis epidemiology, particularly examining how cannabis use patterns, environmental risk factors, and genetic vulnerability interact to influence psychosis risk and presentation. She has made significant contributions to understanding the relationship between population density, social deprivation, and subclinical psychosis across European settings. Her work frequently employs data from the EU-GEI study, a major multinational research initiative investigating gene-environment interactions in psychosis. Analysis of her recent publications (2023-2025) reveals a consistent focus on nuanced aspects of psychosis etiology, with particular attention to the differential effects of cannabis use patterns, the impact of social determinants on psychosis incidence, and the cognitive presentation of psychosis at onset. Her research demonstrates methodological sophistication through the integration of epidemiological, genetic, and clinical approaches. Dr. Tripoli has also contributed to research on mental health during the COVID-19 pandemic, with specific focus on medical student populations in Sicily. Her work on the RISKMet study protocol indicates expanding interests in the metabolic consequences of antipsychotic treatment.

• Public Mental Health
• Sleep Medicine
• Epidemiology
• +7 more

Professor Nick Glozier holds appointments at the University of Sydney within the Central Clinical School (Royal Prince Alfred Hospital) and serves as a theme leader in the ARC Life Course Centre of Excellence . He leads clinical trials at the Brain and Mind Centre focusing on chronic mood/sleep disorders, with funding from NHMRC, industry, and international sources. Education : MA, MSc, MBBS, PhD Clinical Affiliation : Consultant Psychiatrist, Local Health District Community Team Research Themes : Public Mental Health, Sleep Disorders, Workplace Mental Health, Digital Interventions International Collaborations : University of Bergen (Norway), Institute for Research and Development (Sri Lanka), King's College London (UK) His research program spans epidemiology , clinical trials , and health services evaluations , emphasizing mental health in changing psychosocial environments. Recent work explores ketamine therapies , digital health tools for depression, and sleep disorder epidemiology . He coordinates the Psychiatry and Addiction Medicine program in graduate medical education. Scientific Awards : Co-author of WHO's ICF Disability Classification ARC Life Course Centre Theme Leader His supervision includes projects on psychiatric emergency care, digital health implementation for schizophrenia, and neuroeconomic depression markers. Collaborative grants exceed $60M in competitive funding, integrating machine learning and computational psychiatry .

• Human-Computer Interaction
• Digital Health
• Conversational Agents
• +3 more

Randy Klaassen is an Assistant Professor affiliated with the Digital Society Institute and Human Media Interaction research groups. His work focuses on human-computer interaction , digital health , and conversational agents , particularly in healthcare contexts such as genetic counseling and mental health. Research Interests: Developing digital platforms for family communication in genetic counseling Designing compassionate technology for e-mental health applications Integrating sensor technology for health monitoring systems Advancing conversational agents in clinical decision-making Scientific Contributions: His research spans genetic counseling , mental health technology , and sensor-driven health analytics , with a focus on user-centered design and predictive modeling. Recent publications highlight digital platforms for inherited disease management and eating event recognition using multi-sensor fusion. Scientific Awards: Best poster award at CVOI 2022 Activities: Randy has presented on conversational agents in healthcare (2022), VR therapy (2019), and mental health technology (2019), demonstrating his expertise in human-centered design for health applications.

• Adolescent health
• Global health
• HIV/AIDS
• +4 more

Associate Professor Sarah Bernays is an academic in Global Health at the Sydney School of Public Health, University of Sydney. She co-directs the Master of Global Health program and leads a social science research program on community engagement in infectious disease prevention, treatment, and care. Her work focuses on adolescent global health, particularly in low- and high-income countries, addressing sexual and reproductive health, substance use, and HIV/AIDS. Bernays moved from the London School of Hygiene and Tropical Medicine (LSHTM) to the University of Sydney in 2017. She holds affiliations with the Sydney Centre for Healthy Societies, Sydney Southeast Asia Centre, and Sydney Infectious Diseases Institute. Education: She studied Social Anthropology at Edinburgh University and completed a PhD in Medical Sociology at Imperial College London/LSHTM in 2011, focusing on HIV/AIDS in Serbia. Prior to academia, she worked in HIV community programs in the UK, Africa, and the Pacific. Research Interests: Bernays’ current projects include the 'Zvandi Trial' in Zimbabwe, evaluating community peer support for HIV viral load management, and the 'ODYSSEY' study in Uganda and Zimbabwe on adherence support for adolescents on second-line HIV therapy. She also leads the development of a Youth Trials Board model for pediatric clinical trials and co-designs harm reduction interventions for mobile youth in South Africa and Uganda. Grants and Collaborations: Her work involves multidisciplinary teams collaborating across institutions like LSHTM, University College London, and the University of Zimbabwe. Key projects address barriers to healthcare access, stigma, and community engagement in health interventions. She mentors students and researchers, including co-supervising projects on community participation in pandemic response and tuberculosis research. Labs/Teams: Bernays is part of the Sydney Global Maternal and Child Health Network and contributes to initiatives like the Sydney Infectious Diseases Institute, focusing on translational research to improve health outcomes globally.

David R. McDuffView profile

Clinical Professor

• Addiction Psychiatry
• Trauma Psychiatry
• Sports Psychiatry
• +1 more

Dr. David R. McDuff is a Clinical Professor of Psychiatry at the University of Maryland School of Medicine and Adjunct Associate Professor at the Uniformed Services University. He is the founder of the University of Maryland’s Division of Alcohol & Drug Abuse and Addiction Psychiatry Fellowship, and the Sports Psychiatry Program. A retired Army Colonel, he has served as team psychiatrist for the Baltimore Orioles and Ravens, and performance medicine physician for the Indianapolis Colts. His expertise spans addiction psychiatry, trauma psychiatry, and sports psychiatry. He authored Sports Psychiatry: Strategies for Life Balance & Peak Performance (2012), now in three languages. He co-led the International Olympic Committee’s 2019 Consensus Panel on Mental Health in Elite Athletes. Recognitions include the 2015 Distinguished Life Fellow of the American Psychiatric Association and repeated selection as Baltimore’s Top Doc. Educations: B.S. Biology, Spring Hill College (1974) M.D., University of South Alabama College of Medicine (1978) Residency in Psychiatry, Dwight David Eisenhower Army Medical Center (1979–1982) Research Interests: Dr. McDuff focuses on mental health challenges in elite athletes, including substance use disorders, trauma recovery, and performance optimization. His work emphasizes team-based interventions, crisis management, and global policy for athlete well-being. He has published extensively on sports psychiatry strategies and co-authored groundbreaking IOC guidelines. Awards: 2019 IOC Mental Health Workgroup Member 2015 Distinguished Life Fellow, APA Repeated ‘Top Doc’ honors in Addiction Psychiatry Advising & Grants: He mentors athletes and teams globally, with involvement in NCAA and professional league programs. His grants include funding for substance abuse prevention and trauma recovery initiatives. He lectures internationally and maintains active clinical practices in Baltimore. Labs/Teams: Directs University of Maryland’s Sports Psychiatry Program and collaborates with IOC committees. His work is detailed on www.mdsports.net .

Abigail EastburnView profile

Professor

• Clinical Skills Development and Assessment
• Interprofessional Education
• Primary Care Training
• +1 more

Abigail (Abbi) Eastburn (formerly Phillips) is a Professor and clinician educator at the University of California, San Francisco (UCSF), practicing general internal medicine at the SFVA Healthcare System. She serves as Site Director for the UCSF Ambulatory Continuity Clinic at the San Bruno VA and Director of F2 Clinical Skills Learning & Assessment. As a member of the UCSF Academy of Medical Educators, she precepts interprofessional trainees through the VA EdPACT program and acts as a Bridges Coach for medical students. Education: 2020: Teaching Scholars Program, UCSF 2018: Diversity, Equity, and Inclusion Champion Training, University of California 2011: Internal Medicine Residency, UCSF 2008: M.D., UCSF 2001: B.S., Yale University Research Focus: Dr. Eastburn specializes in clinical skills assessment, interprofessional education models, primary care training frameworks, and cross-cultural mentoring methodologies. Her work emphasizes competency-based curricula and healthcare team dynamics. Awards: Calvin Chou PRIME Teaching Award (2016) Academy of Medical Educators Excellence in Teaching Award (2014, 2016) Educational Leadership: She leads interprofessional training initiatives at the San Bruno VA, oversees resident clinical skill development, and mentors trainees through UCSF's Bridges coaching program.

Ben WhalleyView profile

Associate Professor

• Psychology
• Mental Health
• Gambling Behavior
• +4 more

Dr. Ben Whalley is an Associate Professor in the School of Psychology at the University of Plymouth, part of the Faculty of Health. His research focuses on psychological interventions, mental health, gambling behavior, cognitive processes, and neuroscientific mechanisms. He has conducted studies on the impact of meditation, the effects of loot boxes in gaming, and the efficacy of therapies such as Radically Open Dialectical Behavior Therapy (RO-DBT) for refractory depression. His work spans interdisciplinary topics including the psychological effects of the pandemic on gambling and gaming behaviors, the neurobiological roles of cannabinoids, and the application of brief psychological techniques in healthcare settings. Dr. Whalley has also explored the mental health implications of activities like scuba diving and the optimization of treatments for chronic pain and musculoskeletal conditions. Key research trends in his articles include analyzing complex relationships between psychological variables and addictive behaviors, evaluating the cost-effectiveness of novel therapeutic approaches, and investigating the neural mechanisms underlying cognitive phenomena such as attentional processing and memory accuracy. Dr. Whalley's research has contributed to understanding treatment-resistant depression, stress management strategies, and the societal impacts of gaming and gambling. His work bridges clinical psychology, neuroscience, and public health, addressing both individual and population-level challenges.

Tiffany BrownView profile

Senior Lecturer

• Substance Use and Recovery
• Collegiate Recovery Programs
• Self-Harm
• +3 more

Dr. Tiffany Brown is a Senior Lecturer II and Clinical Director in the Couples and Family Therapy graduate program at the University of Oregon’s College of Education. She also directs the Center for Healthy Relationships within the HEDCO Clinic. Her work bridges clinical practice and research, focusing on substance use recovery, self-harm intervention, and mental health support for athletes and marginalized communities. Brown holds certifications as a clinical fellow and approved supervisor with the American Association for Marriage and Family Therapy (AAMFT) and the state of Oregon. Education includes a Ph.D. in Marriage & Family Therapy from Texas Tech University (2009), an M.Ed. in Couples & Family Therapy from the University of Oregon (2005), and a B.S. in Psychology and Sociology from the University of Oregon (2002). She is a first-generation college student, informing her advocacy for equitable educational systems. Research interests span substance use recovery, collegiate recovery programs, self-harm, mental health in athletics, grief and loss (particularly pediatric oncology and intensive care), and anti-racism/social justice in academia and clinical settings. She emphasizes decolonizing spaces, centering marginalized voices, and addressing systemic inequities linked to the ‘war on drugs’ and identity-based disparities. Notable awards include the 2019 Excellence in Supervision Award and the 2014 Early Career Teaching Award from the College of Education. She has contributed to SAMHSA’s BRSS TACS initiative to expand collegiate recovery programs and led crisis response efforts post the 2015 Roseburg mass shooting. Her community engagement includes advisory roles at Courageous Kids (grief support), past leadership in ARHE and Carry it Forward, and board positions advocating for minoritized youth and unhoused individuals. Brown’s advising and grant work focus on advancing recovery science and transforming clinical training through anti-racist frameworks. She collaborates with interdisciplinary medical teams in medical family therapy and is completing a book on female athletes’ mental health (Little, Brown Spark/Hachette). Her clinical and academic leadership integrates family systems theory with contemporary social justice imperatives, prioritizing equitable access and trauma-informed care across settings.

William E. FantegrossiView profile

Professor

• Synthetic Cannabinoids
• Opioid Abuse
• Drug Abuse Pharmacology
• +3 more

William E. Fantegrossi is a Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), College of Medicine. His research focuses on emerging drugs of abuse, including synthetic cannabinoids, cathinones, hallucinogens, and novel opioids. He investigates their pharmacological profiles, toxicity mechanisms, and interactions with established drugs like fentanyl. Fantegrossi leads multiple funded projects, including NIH/NIDA grants exploring synthetic cannabinoid toxicity and ASPET fellowships for undergraduate training. His lab employs behavioral pharmacology techniques in rodents, assessing drug effects on locomotion, thermoregulation, and neurochemistry. He also directs the Behavioral Core of the Center for Translational Neuroscience. Education: Ph.D. in Pharmacology, University of Michigan, 2002 Research Interests: Pharmacology of synthetic cannabinoids (Spice/K2), cathinones (bath salts), and fentanyl analogues Abuse liability testing and neurotoxicity mechanisms Drug interactions contributing to overdose (e.g., fentanyl + cannabinoids) Development of novel therapeutic agents targeting addiction and neurological disorders Grants & Awards: DEA/FDA HHSF223201610079C (PI): In Vivo Pharmacological Studies for Abuse Liability Testing (2016-2021) NIH/NIDA R01 DA039143 (Co-I): Synthetic Cannabinoid Toxicity (2015-2020) NIH/NIGMS P30 GM110702: Behavioral Core Director (2014-2019) Labs & Teams: Leads a multidisciplinary team studying drug abuse mechanisms, including collaborations with chemists, toxicologists, and neuroscientists. His lab supports training programs for undergraduate and medical student researchers through T32 and ASPET fellowships.

Rune EllefsenView profile

Researcher

• Hate crime
• Political crime and violence
• Radicalization and violent extremism
• +6 more

Rune Ellefsen is a Researcher at the Center for Research on Extremism (C-REX) at the University of Oslo, where he conducts research on hate crime, political violence, radicalization, and policing of protest movements. He is also affiliated with RusForsk at Oslo University Hospital, leading qualitative research on heroin-assisted treatment in Norway. His work combines analytical perspectives from social movement studies, criminology, and political violence research. Ellefsen's educational background includes: PhD in Sociology of Law from the University of Oslo (2018), with dissertation "Performing and policing transgressive protest: A relational approach to the SHAC-HLS conflict in Britain (1999–2014)" Prior research in green criminology, including co-editing the book "Eco-Global Crimes" and authoring "Med lov til å pine" His primary research interests focus on the intersection of social movements, political violence, and state responses. Ellefsen examines how hate crimes manifest and how societies respond to them, particularly through his work on the HateCycle project. He investigates the policing of radical protest movements and the dynamics between activists and law enforcement. His research on radicalization prevention explores everyday resistance strategies employed by minority communities, particularly Muslims facing anti-Muslim hostility. Additionally, his work on heroin-assisted treatment examines patient experiences and clinician perspectives on this harm reduction approach. Ellefsen's recent publications reveal a clear trajectory connecting his expertise in social movement dynamics with contemporary issues of hate crime, radicalization, and drug policy. His work bridges theoretical frameworks from criminology and sociology with practical applications in policy development. The articles show a consistent focus on marginalized communities, whether examining the experiences of drug treatment patients, LGBTQI individuals reporting hate crimes, or minority youth confronting racism. His methodological approach combines qualitative analysis with theoretical insights from multiple disciplines. Ellefsen has contributed to several significant research projects: HateCycle project: Exploring the life cycle of hate crimes Radicalization and Resistance project (2019-2022): Examining Muslims' everyday prevention of radicalization Nordic pilot project on Countering violent extremism (2018-2019) Swedish research project on Radicalization and counter-radicalization (2018) HAB project: Evaluation of heroin-assisted treatment His work spans multiple institutional contexts, demonstrating his ability to bridge academic research with practical policy applications in both security and public health domains.